WIL Research Laboratories Overview

  • Founded
  • 1976
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1,300
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 6
  • Investments
  • 4

WIL Research Laboratories General Information

Description

Provider of non-clinical toxicology, pharmacology, metabolism and both clinical and non-clinical bioanalytical services. The company offers developmental and reproductive toxicology, juvenile toxicology, general toxicology, analytical chemistry, neurotoxicology, bioanalytical chemistry, safety pharmacology, pathology, metabolism, surgical models, inhalation toxicology, infusion toxicology, commercial archiving and support services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Primary Office
  • 1407 George Road
  • Ashland, OH 44805
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

WIL Research Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore WIL Research Laboratories‘s full profile, request access.

Request a free trial

WIL Research Laboratories Patents

WIL Research Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2230374-A1 2-(2'hydroxyphenyl)benzotriazoles and process for their preparation Abandoned 27-Mar-1997 0000000000
DE-69810527-T2 2- (2'-hydroxphenyl) benzotriazoles and their use as light stabilizers for organic polymers Expired - Lifetime 27-Mar-1997 0000000000
DE-69810527-D1 2- (2'-hydroxphenyl) benzotriazoles and their use as light stabilizers for organic polymers Expired - Lifetime 27-Mar-1997 0000000000
JP-3265393-B2 2- (2'-hydroxyphenyl) benzotriazole and process for producing the same Expired - Fee Related 27-Mar-1997 0000000000
JP-H1129568-A 2-(2'-hydroxyphenyl)benzotriazole and its production Granted 27-Mar-1997 C07D401/14
To view WIL Research Laboratories’s complete patent history, request access »

WIL Research Laboratories Executive Team (8)

Name Title Board Seat Contact Info
Howard Moody Vice President & Chief Information Officer
Jim Rudar Senior Vice President, Finance & Director, Marketing
You’re viewing 2 of 8 executive team members. Get the full list »

WIL Research Laboratories Board Members (4)

Name Representing Role Since
000 000 000 000000 NOTOX Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »

WIL Research Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

WIL Research Laboratories Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore WIL Research Laboratories‘s full profile, request access.

Request a free trial

WIL Research Laboratories Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 19-Jun-2013 0000000000 Laboratory Services (Healthcare) 00000 000
0000000 00000 13-Feb-2009 0000000000 Laboratory Services (Healthcare)
00 000000 06-Oct-2006 0000000000 Other Pharmaceuticals and Biotechnology
NOTOX 27-Jul-2005 Buyout/LBO 0000 Laboratory Services (Healthcare) 000 00000
To view WIL Research Laboratories’s complete investments history, request access »

WIL Research Laboratories Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 000000 06-Oct-2006 0000000000 Completed
  • 3 buyers
To view WIL Research Laboratories’s complete exits history, request access »